stock-mb-logo-androidstock-mb-logo-ios
Stock Screener App
Free - Play StoreApp Store
InstallInstall
logo
Seres Therapeutics IncMCRB
$1.434.67%-0.07

Seres Therapeutics Inc (MCRB)

Nov 12O1.48H1.48L1.30C1.43Vol39.94k

Seres Therapeutics Inc Stock (MCRB) Forecast

The Seres Therapeutics Inc (MCRB) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $45.27, representing a +3,066% increase from the current price of $1.43. The highest analyst price target is $82.96, and the lowest is $7.58.

Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.

12-Month MCRB Price Target
Average 41.51 (+2,803% Upside)

Is Seres Therapeutics Inc (MCRB) A Buy Now?

Oscillators
NameValueAction
RSI(14)23.29Buy
STOCH(9,6)27.82Neutral
STOCHRSI(14)40.67Neutral
MACD(12,26)-0.38Buy
ADX(14)53.41Sell
William %R-86.46Buy
CCI(14)-96.77Neutral
Buy: 3 · Sell: 1 · Neutral: 3Summary: Neutral
Moving Averages
PeriodSimpleExponential
MA10
1.79
Sell
1.75
Sell
MA20
1.96
Sell
2.01
Sell
MA50
3.05
Sell
2.87
Sell
MA100
4.28
Sell
4.18
Sell
MA200
6.50
Sell
6.83
Sell
Buy: 0 · Sell: 10 · Neutral: 0Summary: Sell

According to our latest analysis, MCRB could be considered a Strong Sell, with 17 technical analysis indicators signaling 3 Buy signals, 11 signaling Sell signals and 3 Neutral signals. This might not be a good time to consider opening new positions on MCRB, as trading bearish markets can be challenging and may result in losses.

  1. RSI (Relative Strength Index): The RSI(14) value of 23.29 indicates that MCRB is oversold. This indicates that MCRB price has experienced a significant decline over a specified lookback period, potentially leading to a rebound.
  2. STOCH (Stochastic Oscillator): The STOCH value of 27.82 indicates that MCRB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  3. STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 40.67 indicates that MCRB is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
  4. ADX (Average Directional Index): The ADX value of 53.41 suggests an extremely strong trend in the market. Such high values are relatively rare and indicate a very robust directional movement.
  5. CCI (Commodity Channel Index): A CCI(14) value of -96.77 indicates that MCRB is still oversold but not to an extreme extent.

Long-term MCRB price forecast for 2026, 2030, 2035, 2040, 2045 and 2050

Based on our analysis about Seres Therapeutics Inc financial reports and earnings history, Seres Therapeutics Inc (MCRB) stock could reach $49.81 by 2030, $249.81 by 2040 and $615.06 by 2050. See the projected annual prices until 2050 of the Seres Therapeutics Inc stock below:

  • Seres Therapeutics Inc (MCRB) is expected to reach an average price of $106.28 in 2035, with a high prediction of $146.53 and a low estimate of $108.96. This indicates an +7,332% change from the last recorded price of $1.43.
  • Seres Therapeutics Inc (MCRB) stock is projected to chart a bullish course in 2040, with an average price target of $224.98, representing an +15,633% change from its current level. The forecast ranges from a conservative $207.53 to a sky-high $249.81.
  • Our analysts predict Seres Therapeutics Inc (MCRB) to change +22,555% by 2045, soaring from $307.73 to an average price of $323.96, potentially reaching $358.44. While $307.73 is the low estimate, the potential upside is significant.
  • Seres Therapeutics Inc (MCRB) stock is expected to climb by 2050, reaching an average of $465.21, a +32,432% change from its current level. However, a wide range of estimates exists, with high and low targets of $615.06 and $459.32, respectively, highlighting the market's uncertainty.

Seres Therapeutics Inc Stock (MCRB) Year by Year Forecast

Seres Therapeutics Inc Stock (MCRB) Price Forecast for 2026

The predicted value for Seres Therapeutics Inc (MCRB) in 2026 is set at an average of $10.13. Estimates vary from a peak of $82.96 to a trough of $1.35, indicating an +608.05% surge from the present price of $1.43.

MonthAverageLowHighChange from today's price
December, 2026$16.38$7.58$82.96+1,045%

Seres Therapeutics Inc Stock (MCRB) Price Forecast for 2027

For 2027, Stockscan's Analyst expects the average price target for Seres Therapeutics Inc (MCRB) is $33.07, with a high forecast of $72.58 and a low forecast of $0.0638. This indicates an +2,213% increase from the last price of $1.43.

MonthAverageLowHighChange from today's price
January, 2027$13.02$2.62$36.29+810.82%
February, 2027$1.87$0.0638$23.59+30.81%
March, 2027$17.17$0.118$28.29+1,101%
April, 2027$1.27$1.56$15.45-10.92%
May, 2027$43.97$2.01$30.17+2,975%
June, 2027$72.72$57.26$62.32+4,986%
July, 2027$77.28$70.99$72.58+5,304%
August, 2027$59.72$62.62$63.75+4,076%
September, 2027$22.47$36.07$49.01+1,472%
October, 2027$20.03$23.76$18.74+1,301%
November, 2027$13.33$1.79$21.19+832.12%
December, 2027$53.98$4.25$58.98+3,674%

Seres Therapeutics Inc Stock (MCRB) Price Forecast for 2028

In 2028, Seres Therapeutics Inc (MCRB) is projected to reach an average price of $12.17, with a high projection of $67.09 and a low estimate of $0.089. This indicates an +751.39% rise from the last price of $1.43.

MonthAverageLowHighChange from today's price
January, 2028$9.33$4.02$67.09+552.62%
February, 2028$13.82$2.04$23.76+866.54%
March, 2028$12.38$12.00$5.28+765.43%
April, 2028$6.13$7.15$3.13+328.66%
May, 2028$6.77$14.22$11.43+373.60%
June, 2028$5.47$0.3734$16.25+282.75%
July, 2028$4.77$2.58$28.50+233.52%
August, 2028$7.92$8.92$6.73+454.08%
September, 2028$7.48$0.089$20.90+422.90%
October, 2028$4.52$7.52$7.43+216.10%
November, 2028$28.07$7.11$25.77+1,863%
December, 2028$39.43$28.25$31.83+2,657%

Seres Therapeutics Inc Stock (MCRB) Price Forecast for 2029

The 2029 price forecast for Seres Therapeutics Inc Stock (MCRB) is $61.79 on average, with a high prediction of $68.18 and a low estimate of $44.12. This represents an +4,221% increase from the previous price of $1.43.

MonthAverageLowHighChange from today's price
January, 2029$65.67$44.12$61.67+4,492%
February, 2029$71.73$66.36$65.43+4,916%
March, 2029$68.58$70.29$68.18+4,696%
April, 2029$59.42$61.02$66.96+4,055%
May, 2029$62.78$62.98$60.18+4,290%
June, 2029$62.13$62.53$61.66+4,245%
July, 2029$65.40$59.71$63.69+4,473%
August, 2029$67.53$65.23$65.53+4,622%
September, 2029$56.28$57.19$61.62+3,836%
October, 2029$59.96$56.97$55.68+4,093%
November, 2029$50.68$55.86$57.41+3,444%
December, 2029$51.39$45.74$43.52+3,494%

Seres Therapeutics Inc Stock (MCRB) Price Forecast for 2030

Seres Therapeutics Inc Stock (MCRB) is expected to reach an average price of $40.98 in 2030, with a high forecast of $49.81 and a low forecast of $33.92. This signifies an +2,766% surge from the last price of $1.43.

MonthAverageLowHighChange from today's price
January, 2030$48.40$51.69$49.81+3,284%
February, 2030$46.51$46.60$44.03+3,152%
March, 2030$49.28$48.15$46.98+3,347%
April, 2030$45.45$46.60$46.33+3,079%
May, 2030$40.47$41.78$40.51+2,730%
June, 2030$39.85$40.04$39.89+2,687%
July, 2030$37.52$39.14$39.46+2,524%
August, 2030$38.33$37.68$37.04+2,581%
September, 2030$37.76$36.77$37.17+2,541%
October, 2030$37.90$38.27$38.00+2,550%
November, 2030$38.43$38.64$38.41+2,588%
December, 2030$31.81$33.92$36.66+2,125%

Similar to MCRB